- New Hope Liuhe‘s preliminary net income for the fiscal year is 473.6 million yuan.
- The company’s preliminary revenue stands at 103.06 billion yuan.
- This revenue figure is below the estimated revenue of 108.27 billion yuan.
- Current analyst recommendations include 6 buy ratings.
- There are no hold ratings from analysts.
- Analysts have issued 2 sell ratings.
A look at New Hope Liuhe Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 1 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have identified New Hope Liuhe as a company with a promising long-term outlook. The company scored high in growth potential, receiving a score of 5 out of 5. This suggests that New Hope Liuhe is positioned to experience significant expansion and development in the future. On the other hand, the company scored lower in dividend and momentum, with scores of 1 and 2 respectively. This indicates that while New Hope Liuhe may not be currently offering high dividends, its growth prospects remain strong.
New Hope Liuhe is recognized for its strength in value, with a score of 4 out of 5, indicating that the company may be considered undervalued based on its current financial standing. However, its resilience score of 2 implies that there may be some areas where the company needs to improve its ability to withstand economic challenges. Overall, investors may find New Hope Liuhe an attractive option for long-term growth potential, especially considering its diverse operations in animal feeds, commercial trading, and other related services.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
